Modulators of γ-Secretase Activity Can Facilitate the Toxic Side-Effects and Pathogenesis of Alzheimer's Disease

Overview of attention for article published in PLOS ONE, January 2013

Altmetric Badge

Mentioned by

news: 1 news outlet

Citations

dimensions_citation: 35 Dimensions

Readers on

mendeley: 55 Mendeley

Summary News Dimensions citations

So far, Altmetric has seen 1 news story.

Semagacestat, a Pseudo γ-Secretase Inhibitor?

Alzforum, 12 Oct 2017

12 Oct 2017 Seven years after semagacestat failed in Phase 3 clinical trials for Alzheimer’s disease, researchers led by…